Benefits and Burdens of FDA Regulations on Global Medical Technology Markets Discussed on May 6
Medtronic's chief regulatory officer to deliver keynote.
Susan Alpert, PhD, M.D., senior vice president and chief regulatory officer for Medtronic, will deliver the keynote address at the "Benefits and Burdens of FDA Regulations on Global Medical Technology Markets" on Friday, May 6, from 8:00 to 11:30 a.m. in the Carlson School's 3M Auditorium.
The event, co-sponsored by the school's Medical Industry Leadership Institute (MILI) and its Center for International Business Education and Research (CIBER), will provide an insightful and candid set of conversations about the challenges facing the medical technology market and the evolving role of governments across the globe.
National governments invest substantial energy and resources to develop life-saving medical technologies. At the same time, they also regulate these markets to ensure patient safety. Is there an explicit trade-off between government regulation and path-breaking innovation? Can regulation restrict medical technology development to the point of critical degradation of the capacity to create new innovations? These and other topics vital to the international health of citizens and the firms that create wealth to support and enhance their standard of living will be discussed.
Panel member at the event will include:
- John J. Alexander, president, Business Development Advisors; founder and chairman, Twin Cities Angels
- Thomas Gunderson, managing director and senior research analyst, Piper Jaffray & Co.
- Ralph Hall, counsel, Baker & Daniels; distinguished professor and practitioner, University of Minnesota Law School
- Richard Manning, executive director, Global Public Policy, Merck & Co., Inc.
- Simon Stevens, executive vice president, UnitedHealth Group; president, Global Health, UnitedHealth Group; chairman, UnitedHealth Center for Health Reform